Novartis announces reduction of 322 jobs at New Jersey facility

Novartis filed a WARN notice indicating it will eliminate 322 positions at its East Hanover, New Jersey site. The reduction is part of a broader restructuring effort aimed at streamlining operations and controlling costs.

The layoffs will affect employees across multiple functions, and the company has not disclosed a specific timeline for the departures. Affected staff are expected to receive severance and outplacement assistance as per standard practice.

The announcement was released alongside reports that OTR and LG Chem are exploring partnerships to develop cancer therapies in China, highlighting continued strategic activity in the sector despite the workforce reduction.

Local officials expressed concern about the impact on the regional economy, noting that the New Jersey plant has been a significant employer in the area.